Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels
- 1 May 2012
- journal article
- research article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 22 (5) , 364-373
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implicationsTrends in Endocrinology & Metabolism, 2010
- Beneficial Metabolic Effects Caused by Persistent Activation of β-Cell M3 Muscarinic Acetylcholine Receptors in Transgenic MiceEndocrinology, 2010
- Hepatic Muscarinic Acetylcholine Receptors Are Not Critically Involved in Maintaining Glucose Homeostasis in MiceDiabetes, 2009
- Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjectsJournal of Affective Disorders, 2009
- Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal modelSchizophrenia Research, 2009
- Insulin sensitivity, adjusted β-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: A nine-month prospective studyDiabetes & Metabolism, 2008
- Insulin resistance following continuous, chronic olanzapine treatment: An animal modelSchizophrenia Research, 2008
- The vagus nerve, food intake and obesityRegulatory Peptides, 2008
- Necessity of intracellular cyclic AMP in inducing gastric acid secretion via muscarinic M3 and cholecystokinin2 receptors on parietal cells in isolated mouse stomachLife Sciences, 2005
- Alterations in the muscarinic M1 and M3 receptor gene expression in the brain stem during pancreatic regeneration and insulin secretion in weanling ratsLife Sciences, 2004